Virtual Reality for Public Speaking Anxiety
(ETC2 Trial)
Trial Summary
What is the purpose of this trial?
Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present multicenter study (conducted through the Exposure Therapy Consortium) is designed to evaluate whether trait versus state positive affectivity is a more effective predictor of exposure therapy outcomes. Further, the investigators will examine whether the predictive significance of trait positive affectivity can be accounted for by examination of baseline levels of self-efficacy, hope, and optimism.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment for public speaking anxiety?
Research shows that virtual reality exposure therapy can significantly reduce public speaking anxiety, with large decreases in anxiety levels reported after just one session. This treatment has been effective both in therapist-led and self-led formats, and improvements were maintained or even increased over time.12345
Is virtual reality exposure therapy safe for treating public speaking anxiety?
The studies suggest that virtual reality exposure therapy is generally safe for treating public speaking anxiety, as no significant safety concerns were reported in the trials. Participants experienced decreased anxiety levels, and the therapy was conducted using affordable consumer VR hardware without adverse effects.12346
How does the virtual reality treatment for public speaking anxiety differ from other treatments?
Research Team
Michael Otto, PhD
Principal Investigator
Boston University
Eligibility Criteria
This trial is for individuals with anxiety disorders, specifically those who experience speech anxiety or social anxiety disorder. Participants should be comfortable using virtual reality (VR) technology as the intervention involves a single-session VR exposure.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
In-person Assessment and Brief Exposure Intervention
Participants undergo in-person assessment and brief exposure intervention for public speaking anxiety
Follow-up
Participants are monitored for public speaking and social anxiety outcomes one week after the intervention
Treatment Details
Interventions
- Single-session VR exposure intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University Charles River Campus
Lead Sponsor
The University of Hong Kong
Collaborator
University of Texas at Austin
Collaborator
Tufts University
Collaborator
The University of New South Wales
Collaborator
Curtin University
Collaborator
Erasmus University Rotterdam
Collaborator
University of Western Sydney
Collaborator
National University of Singapore
Collaborator
Philipps Universität Marburg
Collaborator